Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: a meta-analysis
Metrics: PDF 1184 views | HTML 1747 views | ?
Yuxin Chen1,*, Bei Jia2,*, Yong Liu3, Rui Huang2, Junhao Chen1 and Chao Wu2
1Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu Province, China
2Department of Infectious Disease, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu Province, China
3Department of Experimental Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, 210008, Jiangsu Province, China
*These authors contributed equally to this work
Chao Wu, email: firstname.lastname@example.org
Junhao Chen, email: email@example.com
Keywords: severe fever with thrombocytopenia syndrome, risk analysis, meta-analysis
Received: January 30, 2017 Accepted: June 29, 2017 Published: July 11, 2017
Severe fever with thrombocytopenia syndrome is an emerging life-threatening infectious disease identified in 2009. Given high case-fatality rate among patients with severe fever with thrombocytopenia syndrome, identification of the risk factors at acute phase associated with fatality is crucial for treatment. Therefore, we aimed to meta-analytically evaluate risk factors of fatal clinical outcome of severe fever with thrombocytopenia syndrome. 238 fatal cases and 873 non-fatal cases from 12 studies were included in this meta-analysis. Elder age and high viral load were significantly associated with fatal clinical outcome. Further, severe fever with thrombocytopenia syndrome patients with fatal clinical outcome had significantly reduced level of albumin and platelet count, higher level of serum alanine aminotransferase, aspirate aminotransferase, lactic acid dehydrogenase and creatinine phosphokinase, and prolonged activated partial thromboplastin time, comparing with mild patients. These disturbed parameters function as predictors to warn fatal clinical outcome of the disease. Moreover, ribavirin has a minimal impact to alleviate disease progression of severe fever with thrombocytopenia syndrome. In conclusion, our finding demonstrates a panel of factors associated with fatality of SFTS disease, which have important implications during clinical practice.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.